Merck & Co., Inc.'s Net Worth

$0

Estimate Recalculated Sep 15, 2025 08:39PM EST

Who is Merck & Co., Inc.

Merck & Co., Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Pandion Therapeutics, Inc., Harpoon Therapeutics, Inc., OPGEN INC, BeiGene, Ltd., Organon & Co., ARQULE INC, NGM BIOPHARMACEUTICALS INC, SUTRO BIOPHARMA INC, and Menlo Therapeutics Inc..

SEC CIK

Merck & Co., Inc.'s CIK is 0000310158

Past Insider Trading and Trends

2021 was Merck & Co., Inc.'s most active year for disposing of shares, totalling 1 transactions. Merck & Co., Inc.'s most active month to dispose stocks was the month of May. In 2021 Merck & Co., Inc. cashed out on 253,516,000 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OPGEN INC

Investor
Updated Jun 29, 2016
Form 4
133.70%
4.79M
Jun 29, 2016
8.36M
Purchase
Jun 27
Form 4
109.13%
4.83M
May 24, 2016
9.26M
Purchase
May 19
Form 3
Jul 23, 2015
1.48M
Showing 3 results

BeiGene, Ltd.

Investor
Updated Feb 10, 2016
Form 4
33.59%
7.94M
Feb 10, 2016
31.59M
Options
Feb 08
Form 3
Feb 02, 2016
Showing 2 results

Organon & Co.

Investor
Updated Jun 04, 2021
Form 4
-100.00%
-253.52M
Jun 04, 2021
Disposition
Jun 02
Form 3
May 07, 2021
100.00
Showing 2 results

Pandion Therapeutics, Inc.

Investor
Updated Mar 04, 2021
Form 3
Mar 04, 2021
Showing 1 results

ARQULE INC

Investor
Updated Dec 16, 2019
Form 3
Dec 16, 2019
Showing 1 results

NGM BIOPHARMACEUTICALS INC

Investor
Updated Apr 09, 2019
Form 4
-26.67%
-4.71M
$16.00
Apr 09, 2019
12.96M
Buy-Options
Apr 08
Form 3
Apr 03, 2019
Showing 2 results

SUTRO BIOPHARMA INC

Investor
Updated Oct 02, 2018
Form 4
-96.36%
-72.07M
$15.00
Oct 02, 2018
2.72M
Buy-Options
Oct 01
Form 3
Sep 26, 2018
Showing 2 results

Menlo Therapeutics Inc.

Investor
Updated Jan 24, 2018
Form 3
Jan 24, 2018
1.24M
Showing 1 results

Harpoon Therapeutics, Inc.

Investor
Updated Mar 11, 2024
Form 4
21.40M
$23.00
$492.14M
Mar 11, 2024
1.00K
Purchase
Mar 11
Form 3
Jan 17, 2024
Showing 2 results